ReviewInternational journal of molecular sciences2021

Targeting S1PRs as a Therapeutic Strategy for Inflammatory Bone Loss Diseases-Beyond Regulating S1P Signaling.

Hong YuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.